Monday, July 4, 2016

BRIEF-Amgen says European Xommission approved extended indication for Kyprolis

* European Commission approves extended indication for

Amgen's Kyprolis (carfilzomib) for treatment of relapsed

multiple myeloma patients

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)